MetaVia Inc. — Director's Dealing 2016

Aug 5, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2016-08-04

Reporting Person: Lowenschuss David (Chief Legal Off. & Secretary, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	795127	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$1.344	2025-06-28	Common Stock (2327)		Direct